"Premier Neurology is a neurology practice in Greer, SC that offers patient care in a peaceful environment. Our providers work to help patients create the care team needed to navigate life with MS, from opthamologists to physical therapists, as well as counselors and nutritionists. Premier Neurology has partnered with Intrafusion to provide ongoing care for patients on our premises. Our infusion suite is comfortable and inviting."

During the past decade, Premier Neurology conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Premier Neurology" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Pfizer" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Atara Biotherapeutics" with 1 trials sponsored and "Beijing InnoCare Pharma Tech Co., Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Premier Neurology" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Premier Neurology" are "Migraine" (2 trials), "Multiple Sclerosis" (2 trials), "Primary Progressive Multiple Sclerosis" (2 trials), "Relapsing Multiple Sclerosis" (2 trials) and "Acute Treatment of Migraine" (1 trials). Many other conditions were trialed in "Premier Neurology" in a lesser frequency.

Most popular intervention types in "Premier Neurology" are "Drug" (12 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ocrelizumab" (3 trials), "ATA188" (1 trials), "Antihistamine" (1 trials) and "Cladribine Tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Premier Neurology" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Premier Neurology". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Premier Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Premier Neurology, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".